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Salzburg, Austria
2Department of Cardiology, Clinic of Internal Medicine I, Friedrich Schiller University Jena, Erlanger Allee 101, 07747 Jena, Germany
3Ludwig Maximilian University of Munich, Pettenkoferstrasse 8a, 80336 Munich, Germany
Correspondence should be addressed to Christian Jung; christian.jung@med.uni-jena.de
Received 28 October 2014; Revised 4 December 2014; Accepted 6 December 2014
Academic Editor: James D. Gorham
Copyright © 2015 Michael Lichtenauer et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Introduction. Obesity during adolescence is an increasing problem for both the individual and health care systems alike. InWestern
world countries, childhood adiposity has reached epidemic proportions. It is known that elevated levels of proinflammatory
cytokines can be found in the plasma of obese patients. In this study, we sought to determine the relation between IL-12p40, IL-
12p70, and Interleukin-16 (IL-16) in overweight adolescents. Materials and Methods. Seventy-nine male Caucasian adolescents
aged 13–17 years were included in this study. Thirty-seven of them had a body mass index (BMI) above the 90th age-specific
percentile. Il-12p40, IL-12p70, and IL-16 were measured from plasma using Luminex multiplex technology. Results. Both IL-
12p40 and IL-16 concentrations were significantly increased in overweight subjects compared to normal weight controls (IL-
12p40: 1086.6 pg/mL± 31.7 pg/mL SEM versus 1228.6 pg/mL± 43.5 pg/mL SEM; IL-16 494.0 pg/mL± 29.4 pg/mL SEM versus
686.6 pg/mL± 52.5 pg/mL SEM, 𝑃 < 0.05 and 𝑃 < 0.01, resp.). No differences were found for IL-12p70. Conclusions. Based on
these results, we believe that the increased levels of IL-12p40 and IL-16 are associated with an ongoing inflammatory response in
obese individuals and could lead to the development of disease conditions related to obesity.
1. Introduction
The development of obesity in children and adolescents
has reached almost epidemic proportions in industrialized
countries of theWesternworld since 1980.More than a fifth of
all 12–19 year olds in theUnited States in 2012were considered
obese [1]. Adolescent adiposity is also closely related to
persistent obesity in adult patients [2]. A plethora of studies
has shown that higher body mass index (BMI) or other
measures of obesity in children and adolescents are associated
with adverse alterations of lipoprotein ratio, hypertension,
insulin resistance, and diabetes [3, 4]. Moreover, abdominal
obesity is also the hallmark for the metabolic syndrome (MS)
as excess body weight is accompanied with hypertension,
elevated blood glucose levels, and hyperlipidemia. Obesity
also impairs the outcome in many chronic autoimmune
diseases such as asthma.
The high prevalence of obesity in mostWestern countries
also represents immense costs for health care systems. US
studies showed that obesity in children is accompanied with
higher hospitalization rates for comorbidities of obesity and
drug prescription costs. Furthermore, it was shown that an
elevated BMI was associated with 14.1 billion US dollars only
for nonhospitalization expenditures [5].
Research of recent years showed that smoldering inflam-
matory processes in adipose tissue are present in overweight
patients. Also in children, obesity was accompanied with
higher concentrations of C-reactive protein indicating a low
grade inflammatory state in these subjects [6].
This ongoing inflammation even at a low level could serve
as an elicitor for endothelial stress reactions during the devel-
opment of atherosclerosis over the years.This collectivization
of permanent inflammation and endothelial dysfunction
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is causative for several cardiovascular pathologies such as
coronary heart disease or hypertension which are more likely
to occur in obese patients. A vast number of studies have
investigated proinflammatory mediators like tumor-necrosis
factor (TNF) or Interleukin-6 in adipose patients. However,
the signaling axis via Interleukin-12 (IL-12) and Interleukin-
16 (IL-16) has not yet received much attention in this context.
Here, we tried to examine the association of IL-12p40, IL-
12p70, and IL-16 with obesity in a study cohort of overweight
adolescents.
IL-12 is a major factor in early inflammatory responses
and in the generation of T-helper type 1 (Th1) cells [7].
Elevated levels of IL-12 were thought to be related to the
pathogenesis of autoimmune diseases associatedwith inflam-
matory reactions such as multiple sclerosis, arthritis, and
insulin dependent diabetes [8–12]. Il-12 consists of a heavy
chain (p40 subunit) and a light chain (p35 subunit) which
are linked covalently by disulfide bonds to form the p70
molecule [13, 14]. Moreover, dendritic cells and macrophages
were also shown to secrete the p40 subunit. The p40 subunit
can also serve as a chemoattractant for macrophages [15] and
dendritic cells [16] and induces the secretion of TNF-alpha
and IL-16 in microglia cells and macrophages [17].
IL-16, also known as a leukocyte chemoattractant factor
(LCF), is considered a proinflammatory cytokine and is pro-
duced by T-cells but also neutrophils andmonocytes. It could
promote migration of lymphocytes, induce the expression of
proinflammatory factors, andmodulate apoptosis. Moreover,
peripheral bloodmononuclear cells (PBMC),monocytes, and
macrophages, but not CD4+ T-cells, were shown to secrete
Interleukin-1beta, IL-6, and TNF-alpha upon stimulation
with IL-16 [18].
The aim of this study was to investigate IL-12p40, IL-
12p70, and IL-16 in overweight adolescents and their associ-
ation with anthropometrical measurements of obesity.
2. Methods
2.1. Study Subjects. The experimental protocol for this study
was approved by the local ethics committee (Friedrich-
Schiller-University, Jena, Germany). All study subjects and
their parents were provided with information on the course
of the study and written informed consent was obtained.
All experiments were performed in accordance with the
principles of the Declaration of Helsinki and Good Clinical
Practice. In total, 79 voluntary male individuals aged 13–
17 years going to schools in the area of greater Jena were
included in this study. Of these, 37 (46%) had a body mass
index (BMI) above the 90th percentile according to German
charts [19]. After receipt of informed consent, the following
parameters were recorded in one consultation: age, body
height, body weight, heart rate, systolic and diastolic blood
pressure, BMI, waist circumference, exercise rate (more or
less than 3 hours per week), and family history of diabetes or
cardiovascular disease.Waist circumference wasmeasured as
described previously [20]. In brief, waist circumference was
measured during minimal respiration to the nearest 0.1 cm at
the level of the iliac crest.
2.2. Blood Samples. All blood samples were collected by
venipuncture from an antecubital vein using heparin and
EDTA anticoagulated tubes in themorning after an overnight
fast. The tubes were immediately processed and centrifuged
within 60 minutes after blood withdrawal. Standard plasma
parameters were obtained from the Department of Clinical
Chemistry at the University Hospital Jena: high-density
lipoprotein (HDL; mmol/L), low-density lipoprotein (LDL;
mmol/L), triglycerides (mmol/L), C-reactive protein (CRP,
mg/L; high sensitivity assay), and hematological parameters
(e.g., counts for leukocytes and erythrocytes). Furthermore,
aliquots of obtained plasma samples were stored at −80∘ until
cytokine measurements were conducted.
2.3. Cytokine Measurements. The quantitative determination
of humanTNF-alpha, IL-6, IL-10, IL-12p40, IL-12p70, and IL-
16 was performed from immediately frozen heparin plasma
(−80∘ Celsius). Cytokine concentrations were determined
using Bio-Plex technology according to the manufacturer’s
instructions (Bio-Rad, Hercules, USA). Summarily, fluores-
cently dyed microspheres coated with capture antibodies
bind to relevant cytokines in a sandwich immunoassay
format. Unbound sample is removed in a washing step and
a specific protein can be detected with a fluorescently labeled
antibody. Quantitative measurements of cytokine levels were
performed in a Luminex analyzer as previously described
[21].
2.4. Statistical Analysis. Statistical analysis was performed
using SPPS (21.0, SPSS Inc., USA) and GraphPad Prism soft-
ware (GraphPad Software, USA). All data are given as mean
± standard error of the mean (SEM). IL-12p40, IL-12p70,
and IL-16 concentrations between groups were compared
using the Mann-Whitney 𝑈 test. Baseline characteristics
were compared using the two-sided Student’s 𝑡-test. In order
to further explore the association between cytokines and
patient characteristics, correlation analysis was performed
(using Spearman correlation coefficient). The Bonferroni-
Holm method was used to correct for multiple testing. 𝑃
values < 0.05 were considered statistically significant. A 𝑃
value of <0.05 was indicated as ∗ and a 𝑃 of < 0.01 as ∗∗.
3. Results
Baseline characteristics for all 79 participants in this study are
presented in Table 1 (see also [22–25]). Significant differences
were found for weight, BMI, waist circumference, systolic
blood pressure, erythrocytes, MCV, MCH, thrombocytes,
monocytes, high sensitive C-reactive protein, HbA1c, creati-
nine, and high-density lipoprotein. As expected, overweight
adolescents evidenced higher body weight, BMI, waist cir-
cumference, and lower high-density lipoprotein. Moreover,
overweight subjects also showed higher levels of C-reactive
protein indicating low grade inflammation.
Plasma concentration for both IL-12p40 and IL-16 was
also significantly increased in the overweight group (Fig-
ure 1). In the control group, IL-12p40 was found at a concen-
tration of 1086.6 pg/mL (±31.7 pg/mL SEM). IL-16 levels were
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Table 1: Demographic characteristics.
Normal weight Overweight adolescents Significance
𝑛 42 37
Age 15.4 ± 0.9 15.0 ± 1.4 ns
Height (cm) 176 ± 8 174 ± 9 ns
Weight (kg) 63 ± 7.6 98 ± 19.1 <0.001
BMI 20.48 ± 1.80 32.43 ± 5.20 <0.001
Waist circumference (cm) 73 ± 5 101 ± 13 <0.001
Heart rate (per minute) 78 ± 17 78 ± 11 ns
Systolic blood pressure (mmHg) 120 ± 11 134 ± 17 0.008
Diastolic blood pressure (mmHg) 72 ± 9 72 ± 9 ns
Leukocytes (×109/L) 6.4 ± 1.6 6.6 ± 1.8 ns
Erythrocytes (×1012/L) 5.2 ± 0.3 5.3 ± 0.4 0.042
Hemoglobin (mmol/L) 9.4 ± 0.5 9.2 ± 0.7 ns
Hematocrit 0.44 ± 0.02 0.43 ± 0.03 ns
MCV (fL) 85 ± 3 81 ± 4 <0.001
MCH (fmol) 1.82 ± 0.06 1.74 ± 0.10 <0.001
MCHC (mmol/L) 21.50 ± 0.36 21.57 ± 0.58 ns
Thrombocytes (×109/L) 244 ± 54 269 ± 38 0.02
Neutrophils (×109/L) 3.34 ± 1.46 3.46 ± 1.40 ns
Monocytes (×109/L) 0.48 ± 0.14 0.58 ± 0.14 0.003
Lymphocytes (×109/L) 2.35 ± 0.55 2.34 ± 0.65 ns
HbA1c (%) 5.04 ± 0.28 5.27 ± 0.25 <0.001
Creatinine (𝜇mol/L) 84.71 ± 8.46 73.97 ± 12.13 <0.001
Cholesterol (mmol/L) 4.01 ± 0.80 4.08 ± 0.75 ns
High-density lipoprotein (mmol/L) 1.29 ± 0.22 1.09 ± 0.22 <0.001
Low-density lipoprotein (mmol/L) 2.44 ± 0.83 2.55 ± 0.70 ns
Triglycerides (mmol/L) 0.98 ± 0.56 1.12 ± 0.76 ns
High sensitive C-reactive protein (mg/L) 0.52 ± 1.37 2.95 ± 3.51 <0.001
TNF-alpha (pg/mL) 69.65 ± 5.21 62.32 ± 4.73 ns
IL-6 (pg/mL) 7.01 ± 0.82 7.48 ± 0.96 ns
IL-10 (pg/mL) 13.21 ± 1.86 18.62 ± 4.47 ns
494.0 pg/mL (±29.4 pg/mL SEM). In overweight adolescents,
IL-12p40 was increased to 1228.6 pg/mL (±43.5 pg/mL SEM,
𝑃 = 0.035) and IL-16 to 686.6 pg/mL (±52.5 pg/mL SEM, 𝑃 =
0.0026). No differences were found for IL-12p70 (7.48 pg/mL
± 0.72 pg/mL SEM versus 7.20 ± 1.33 pg/mL SEM, 𝑃 = 0.86).
Also no significant differences were found for TNF-alpha, IL-
6, and IL-10 between the groups.
In order to further explore the association of IL-12p40 and
IL-16 with subject parameters, we performed a correlation
analysis. Correlations between clinical characteristics and IL-
12p40 and IL-16 are depicted in Figures 2 and 3. IL-12p40 and
IL-16 correlated significantly with anthropometrical parame-
ters of obesity (body weight, BMI, and waist circumference).
Of interest was that also a strong correlation to inflammatory
and hematological parameters was found (Table 2). IL-12p70
did not correlate with baseline parameters. Moreover, the
exercise rate of participating subjects did not correlate with
IL-12p40 or IL-16 levels.
4. Discussion
Obesity strongly contributes to the development of cardio-
vascular pathologies and other morbidities such as diabetes.
Primarily in Western world countries, the incidence of
obesity is increasing over the last decades leading to many
socioeconomic problems.
In obese patients, low grade inflammation is present
as higher levels of proinflammatory cytokines were found
in these individuals. With this current study, we aimed
to expand the knowledge on cytokine regulation in obese
adolescents with the main focus on the IL-12/IL-16 axis. As
previous studies showed that IL-12p40 leads to increased
secretion of IL-16 [17] which in turn further induced the
release of many proinflammatory cytokines such as TNF-
alpha and IL-6 from mononuclear cells, we believed that
the regulatory mechanism between IL-12 and IL-16 signaling
could be of greater importance in adipose children and adults.
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Figure 1: Plasma levels of IL-12p40 (a) and IL-16 (b) in overweight and normal weight adolescents. Data is shown as mean ± standard error
of the mean, 𝑛 = 79.





















































Figure 2: Association (correlation analysis) for IL-12p40 with weight (a), BMI (b), and waist circumference (c).
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Figure 3: Correlation analysis for the association between IL-16 and weight (a), BMI (b), and waist circumference (c).
Table 2: Correlation of IL-12p40 and IL-16 with lab parameters,
indicated as Spearman correlation coefficient (𝑅).
IL-12p40 IL-16
Leukocytes (×109/L) 0.305∗∗ 0.286∗
Neutrophils (×109/L) 0.210ns 0.285∗
Monocytes (×109/L) −0.121ns −0.092ns
Lymphocytes (×109/L) −0.021ns −0.137ns






We found that significantly higher concentrations of IL-
12p40 and IL-16 but not IL-12p70 are present in the plasma of
overweight adolescents. Levels of IL-12p40 and IL-16 corre-
lated also significantly with anthropometrical measurements
of obesity such as weight, BMI, and waist circumference. In
this current study, we also analyzed serum concentrations
of other cytokines, such as TNF-alpha, IL-6, and IL-10.
However, levels of these cytokines did not differ significantly
between groups.
Interestingly, relevant correlations were found when
comparing levels of IL-12p40 and IL-16 with hematological
parameters (leukocytes and neutrophils but not monocytes
and lymphocytes). This could relate to the fact that slightly
higher white blood cell counts were found in obese subjects.
We hypothesized that the state of permanent low grade
inflammation could be causative for these elevated levels of
immune cells in the peripheral circulation as also higher
levels of C-reactive protein were found. As IL-16 is mainly
secreted by neutrophils, monocytes, dendritic cells [26], and
CD8+ T-cells [27, 28], the higher number of these cell
types could be also associated with the higher concentra-
tions of IL-16 in the plasma of overweight probands. In
one of our previous studies, we have shown that IL-16 is
secreted in upon activation induced cell death by PBMC after
coincubation with antithymocyte globulin [29]. IL-16 can
cause the release of other proinflammatory cytokines and the
process of ongoing inflammation is further substantiated in
overweight patients subsequently leading to the progression
of pathologies associated with adiposity.
Moreover, IL-16 is also involved in many autoimmune
disease conditions [30] such as inflammatory bowel disease
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[31], rheumatoid arthritis [32], and airway hyperrespon-
siveness [33]. Many previous studies have determined a
connection between childhood obesity and asthma [34, 35].
Obesity also increases the risk to develop rheumatoid arthritis
[36]. In a mouse model of high-fat diet-induced obesity,
it was shown that adiposity could lead to exacerbation of
inflammatory bowel disease [37].
Interestingly, other prominent inflammatory mediators
such as TNF-alpha and IL-6 showed no significant differences
between the two study groups. One could speculate that the
IL-12p40/IL-16 axis might be a more forefront proinflamma-
tory signaling pathway in the earlier stages of obesity related
disease conditions as they were likely present in our cohort of
adolescents compared to the inflammatory milieu found in
adult patients.
5. Limitations
Previous studies showed that IL-16 is upregulated within the
adipose tissue of obese mice [38]. Based on our results, we
cannot definitively distinguish the main origin of IL-16 as we
only analyzed serum samples and not tissue samples of study
subjects. Further studies are warranted in order to decode
mechanisms leading to the expression of IL-12p40, IL-16,
and other inflammatory factors in the context of obesity. It
would be of great interest to identify cell types being the
main source for the proinflammatory response in adipose
patients. This knowledge would be of considerable impor-
tance to provide a better understanding of pathophysiological
mechanisms induced by low grade inflammation and might
help to develop new treatment strategies to counteract disease
progression.
6. Conclusion
In summary, we conclude that the heightened levels of
cytokines of the IL-12/IL-16 axis are involved in pathophysio-
logical conditions that are found in overweight adolescents.
Notably, IL-12p40 and IL-16 but not IL-12p70 are elevated
in overweight adolescents, correlating with different anthro-
pometrical parameters of obesity. Increased levels of these
mediators could lead to the progression of diseases associated
with obesity and the metabolic syndrome.
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